Health
A new polymersome-based SARS-CoV-2 nanovaccine elicits robust immunity – News-Medical.Net
As newer vaccines are being developed to combat the ongoing pandemic of coronavirus disease 2019 (COVID-19), targeting the pathogen, severe acute respiratory syndrome…
As newer vaccines are being developed to combat the ongoing pandemic of coronavirus disease 2019 (COVID-19), targeting the pathogen, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new preprint research paper posted to the bioRxiv* server describes a new subunit nanovaccine that appears to have robust immunogenicity and neutralizing activity.
New approaches to spike-based vaccines
Both the viral spike antigen and its receptor-binding domain (RBD), which elicit highly potent neutralizing…
-
Noosa News22 hours agoMan dies after stabbing in inner-city unit
-
General11 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts
-
Noosa News23 hours agoAgriculture department confirms US beef not banned in Australia
-
General17 hours agoSector warns Coalition’s plan to limit overseas students ‘straight out of Trump’s playbook’